Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Predicted structure of MIF/CD74 and RTL1000/CD74 complexes.
Serum pharmacokinetics and cerebrospinal fluid concentration analysis of the new IgG4 monoclonal antibody GNbAC1 to treat multiple sclerosis: a Phase 1 study.
Epidural blood patch in a patient with multiple sclerosis: is it safe?
PEGylated interferon beta-1a in the treatment of multiple sclerosis - an update.
Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis.
Huperzine A ameliorates experimental autoimmune encephalomyelitis via the suppression of T cell-mediated neuronal inflammation in mice.
Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis.
Treating multiple sclerosis with monoclonal antibodies: a 2013 update.
Meralgia paresthetica after subcutaneous injection of glatiramer acetate.
Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects.
A randomized blinded trial of combination therapy with cyclophosphamide in patients-with active multiple sclerosis on interferon beta.
Disease Modifying Drugs in Multiple Sclerosis: Mechanisms of Action and New Drugs in the Horizon.
Fatigue in multiple sclerosis - A brief review.
Emerging tumefactive MS after switching therapy from interferon-beta to fingolimod: A case report.
Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis.
Management of children with multiple sclerosis.
A qualitative exploration of the impact of a 12-week group exercise class for those moderately affected with multiple sclerosis.
Anti-phospholipid antibodies are associated with response to interferon-beta1a treatment in MS: results from a 3-year longitudinal study.
Influence of pregnancy on neuromyelitis optica spectrum disorder.
Synthon obtains approval for glatiramer acetate 20 mg/mL in Europe
Improving Hand Functional Use in Subjects with Multiple Sclerosis Using a Musical Keyboard: A Randomized Controlled Trial.
Evaluation of sexual function in women at two stages of multiple sclerosis.
Cognitive impairment as unusual first manifestation in late-onset relapsing-remitting multiple sclerosis.
Identification of protein networks involved in the disease course of experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.
Effect of treatment with interferon beta-1a on changes in voxel-wise magnetization transfer ratio in normal appearing brain tissue and lesions of patients with relapsing-remitting multiple sclerosis: a 24-week, controlled pilot study.

Pages